The Wayback Machine - http://web.archive.org/web/20250118151053/https://finance.yahoo.com/sectors/healthcare/
Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
6.436T
Market Weight
9.52%
Industries
11
Companies
1206
Healthcare S&P 500 ^GSPC
Loading Chart for Healthcare
DELL

Day Return

Sector
0.25%
S&P 500
1.00%

YTD Return

Sector
1.90%
S&P 500
1.52%

1-Year Return

Sector
0.98%
S&P 500
25.82%

3-Year Return

Sector
1.64%
S&P 500
28.61%

5-Year Return

Sector
36.78%
S&P 500
80.58%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
1.90%
Drug Manufacturers - General
32.83%
-1.94%
Medical Devices
13.49%
5.22%
Healthcare Plans
12.39%
3.66%
Diagnostics & Research
11.35%
4.33%
Biotechnology
10.73%
-1.36%
Medical Instruments & Supplies
8.41%
6.87%
Medical Care Facilities
2.96%
4.73%
Drug Manufacturers - Specialty & Generic
2.72%
3.51%
Medical Distribution
2.60%
5.93%
Health Information Services
2.34%
5.91%
Pharmaceutical Retailers
0.17%
32.90%

Note: Percentage % data on heatmap indicates Day Return

Largest Companies in This Sector

View More
Table View
Heatmap View
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
725.72 999.43 10.32% 652.652B -4.21% -5.99%
Buy
509.76 625.10 7.42% 469.124B -0.16% +0.77%
Buy
147.03 175.98 5.60% 353.992B -0.50% +1.67%
Buy
171.56 208.90 4.79% 303.171B -1.23% -3.46%
Buy
97.92 133.43 3.92% 247.702B -2.76% -1.57%
Buy
559.65 657.43 3.38% 214.066B -0.37% +7.58%
Buy
592.64 539.24 3.34% 211.086B +1.47% +13.54%
Buy
113.48 130.24 3.11% 196.827B -0.38% +0.33%
Buy
238.36 288.34 2.72% 172.161B -1.46% +3.84%
Buy
26.30 32.62 2.36% 149.042B -0.72% -0.87%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
140.18 36.396B 0.09% +1.90%
258.53 18.975B 0.10% +1.91%
132.65 6.463B 0.45% +0.33%
87.97 6.369B 0.35% -2.32%
61.84 4.4B 0.40% +5.98%

Mutual Fund Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
182.55 40.511B 0.30% +0.10%
76.97 40.511B 0.30% +0.10%
129.35 18.975B 0.10% +1.94%
80.91 13.014B 0.80% +1.51%
80.71 13.014B 0.80% +1.48%

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

  • Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

    In this edition, MCOs bracing for policy changes; Hong Kong real estate in a good state; Wayfair stock worth building a position in; and Macy's, Akzo Nobel, and Truist Financial.

     
  • Analyst Report: Unitedhealth Group Inc

    By revenue, UnitedHealth Group is the nation's largest publicly traded managed care company. It operates through two business segments, UnitedHealthcare and Optum. UnitedHealthcare provides healthcare benefits through four membership groups: Employers & Individual, Medicare & Retirement, Community & State, and International. Optum is a health services business that serves payers, care providers, employers, governments, life science companies, and consumers. OptumInsight uses advanced data analytics and technology to help optimize the performance of clients. Optum includes OptumRx, which operates a pharmacy benefit management service (PBM).

    Rating
    Price Target
     
  • Market Update: BK, PNC, UNH

    Stocks are solidly higher at midday on Friday and are on track to have the best week so far in 2025. Good news on inflation this week brought expectations that the Federal Reserve will indeed cut interest rate at some point in 2025 (we believe in the second half) and earnings season is off to a strong start with generally positive results from banks. Meanwhile, there is some progress in one of the global hotspots, as a ceasefire is due to take hold in the conflict between Israel and Hamas.

     
  • Analyst Report: Novo Nordisk A/S

    With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

    Rating
    Price Target
     

From the Community

Healthcare News